Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)
NCT03322930 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2019-12-23
Summary
A new fundus-guided microperimeter (MP-3S) has been developed by Nidek, Inc. to track the fundus of the patient and present stimuli in specific anatomically-defined locations. Furthermore, this tracking means that exactly the same locations can be tested on subsequent (follow-up) visits. The investigators will use a method called two-color perimetry to map rod and cone sensitivity on this device. With this technique, the sensitivity difference (blue-red) to chromatic test stimuli can be used to determine whether rods, cones or both photoreceptor systems mediate the threshold at a given location in the macula.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Rod sensitivity
diagnostic test for rod loss in central retina
Sponsors & Collaborators
-
Retina Foundation of the Southwest
lead OTHER
Principal Investigators
-
David G Birch, PhD · Retina Foundation of the Southwest
Eligibility
- Min Age
- 10 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-10-01
- Primary Completion
- 2019-03-01
- Completion
- 2019-03-01
Countries
- United States
Study Locations
More Related Trials
-
Evaluation and Treatment of Patients With Retinal Disease
NCT00005784 ·Status: COMPLETED
-
A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration
NCT05230537 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
NCT06557460 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD).
NCT01624636 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa
NCT00447980 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
NCT01535950 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration
NCT02848313 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration
NCT01089517 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Implantation of Retinal Pigment Epithelium in Subjects with Acute Wet Age Related Macular Degeneration
NCT01691261 ·Status: COMPLETED ·Phase: PHASE1
-
Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy
NCT01003691 ·Status: COMPLETED ·Phase: PHASE1
-
Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
NCT04339764 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
NCT01024998 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa
NCT06242379 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration
NCT02725762 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa
NCT00458575 ·Status: TERMINATED ·Phase: PHASE1
-
Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases
NCT02755428 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD)
NCT01186432 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD
NCT00320775 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
NCT03295877 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation
NCT02868424 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)
NCT00056823 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of R:GEN as Intervention in Subjects With Early Stages of AMD for Safety and Exploratory Efficacy Outcomes
NCT04776031 ·Status: COMPLETED ·Phase: NA
-
Stem Cell Therapy for Outer Retinal Degenerations
NCT02903576 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD
NCT02590692 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)
NCT02110225 ·Status: COMPLETED ·Phase: PHASE1/PHASE2